The city of High Point, North Carolina, currently has 1 active clinical trials seeking participants for COVID19 research studies.
Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
Recruiting
This is a multi-center, randomized, triple-blind, placebo-controlled (RCT) study to evaluate the efficacy and safety of Dapsone in older adults, and/or in adult patients (≥40yrs of age) with at least one high-risk comorbidity, among those with confirmed SARS-CoV-2 infection. 3000 infected patients diagnosed with COVID-19, non-hospitalized at the time of enrollment, meeting all inclusion and no exclusion criteria will be randomized (1:1 allocation ratio) to receive either Dapsone or placebo tabl... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
02/22/2022
Locations: Peters Medical Research, LLC, High Point, North Carolina
Conditions: COVID-19